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PCardiac Imaging
The Coronary Artery Calcium Score and Stress
Myocardial Perfusion Imaging Provide Independent
and Complementary Prediction of Cardiac Risk
Su Min Chang, MD, Faisal Nabi, MD, Jiaqiong Xu, PHD, Leif E. Peterson, PHD, Arup Achari, MD,
Craig M. Pratt, MD, John J. Mahmarian, MD
Houston, Texas
Objectives This study sought to examine the relationship between coronary artery calcium score (CACS) and single-photon
emission computed tomography (SPECT) results for predicting the short- and long-term risk of cardiac events.
Background The CACS and SPECT results both provide important prognostic information. It is unclear whether integrating
these tests will better predict patient outcome.
Methods We followed-up 1,126 generally asymptomatic subjects without previous cardiovascular disease who had a
CACS and stress SPECT scan performed within a close time period (median 56 days). The median follow-up was
6.9 years. End points analyzed were total cardiac events and all-cause death/myocardial infarction (MI).
Results An abnormal SPECT result increased with increasing CACS from 1% (CACS 10) to 29% (CACS 400)
(p  0.001). Total cardiac events and death/MI also increased with increasing CACS and abnormal SPECT re-
sults (p  0.001). In subjects with a normal SPECT result, CACS added incremental prognostic information, with
a 3.55-fold relative increase for any cardiac event (2.75-fold for death/MI) when the CACS was severe (400)
versus minimal (10). Separation of the survival curves occurred at 3 years after initial testing for all cardiac
events and at 5 years for death/MI.
Conclusions The CACS and SPECT findings are independent and complementary predictors of short- and long-term cardiac
events. Despite a normal SPECT result, a severe CACS identifies subjects at high long-term cardiac risk. After a
normal SPECT result, our findings support performing a CACS in patients who are at intermediate or high clinical
risk for coronary artery disease to better define those who will have a high long-term risk for adverse cardiac
events. (J Am Coll Cardiol 2009;54:1872–82) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.05.071i
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y noncontrast cardiac computed tomography, is known to
redict subsequent patient outcome (1,2). Likewise, stress-
nduced perfusion defects on single-photon emission com-
uted tomography (SPECT) identify low- and high-risk
roups among heterogeneous populations of both symp-
omatic (3) and asymptomatic (4) patients. However, both
esting modalities are imprecise in risk stratification in that
atients with a normal stress SPECT result still have a low but
ell-defined annual risk of cardiac death and/or myocardial
nfarction (MI), whereas most patients with a moderate or
evere CACS do not develop a subsequent cardiac event.
rom the Methodist DeBakey Heart and Vascular Center and The Methodist
ospital Research Institute, The Methodist Hospital, Houston, Texas. This study
as supported in part by HeartScan-Houston (1994 to 2002), whose representatives
ssisted in the initial data collection.d
Manuscript received March 19, 2009; revised manuscript received May 7, 2009,
ccepted May 25, 2009.Thus, the purpose of this study was to examine whether
ntegration of CACS results with those of stress SPECT
ould improve risk prediction in a group of generally
symptomatic patients without clinically apparent coronary
rtery disease (CAD).
ethods
tudy population. From December 1995 to May 2006,
,175 subjects without a previous history of CAD under-
ent both a CACS determination by electron beam com-
uted tomography and stress SPECT imaging (within a
edian of 56 days) for clinically indicated reasons. The
linically indicated reason for performing a CACS was to
etermine the presence and extent of atherosclerotic plaque
urden among asymptomatic subjects with risk factors for
AD and in those with atypical chest pain symptoms
nd/or a normal SPECT study result. The SPECT study
as performed to evaluate chest pain symptoms and/or to
etermine whether myocardial ischemia was present in
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November 10, 2009:1872–82 CACS and SPECT for Predicting Riskubjects who had an abnormal CACS result. No one had
oronary revascularization between tests. Of these 1,175 sub-
ects, 1,126 (95.8%) were included in the final risk analyses
ecause they had complete clinical follow-up and also had
ssessment of their vital status through the Social Security
eath Index.
lectron beam computed tomography. Electron beam com-
uted tomography was performed on an Imatron C-150
Imatron, Inc., South San Francisco, California) computed
omography scanner with a 100-ms exposure time and a
0-cm field of view. With electrocardiographic (ECG)
ating, 32 consecutive images were obtained in diastole at
-mm intervals. Coronary calcification was defined as a
yperattenuating lesion of 130 Hounsfield units with an
rea equal to 3 pixels (1.02 mm2). The CACS was
alculated using the standard Agatston criteria (5) and was
eported as normal (CACS 10), mild (CACS 11 to 100),
oderate (CACS 101 to 400), or severe (CACS 400) (6).
tress SPECT imaging. Stress and rest SPECT imaging
ere performed with thallium-201 (67%), technetium-99m
estamibi (21%), or technetium-99m tetrofosmin (12%)
ccording to standard American Society of Nuclear Cardi-
logy guidelines (7). Most subjects (84%) underwent exer-
ise stress, but 14.1% received adenosine and 1.9% had
obutamine using standard infusion protocols (7). Medica-
ions such as nitrates and beta-blockers were stopped at least
2 h before testing. An ischemic ECG response was defined
s a 1-mm ST-segment depression occurring 80 ms
fter the J point. All exercise ECGs were interpreted by
esearchers who had no knowledge of CACS or SPECT
esults. The Duke treadmill score was calculated in all
ubjects undergoing exercise stress and was defined as low
5), intermediate (10 to 4), or high (11) risk (8).
The SPECT images were visually interpreted in all 3
tandard projections, along with the gated SPECT and raw
mage data to assess for study normalcy/abnormalcy and to
etermine whether perfusion defects were fixed, partially
eversible, or completely reversible. Quantitative SPECT
as performed by a single investigator (J.J.M.) using a
reviously validated automated program to determine the
xtent and severity of left ventricular (LV) perfusion defect
ize (PDS) and the extent of scintigraphic scar and ischemia
9). The ischemic PDS was calculated based on the change
n counts from the stress to the rest images. A stress-
nduced total PDS 15% or an ischemic PDS 10%
efined high risk for cardiac events (9,10).
ollow-up and outcomes. Clinical follow-up was prospec-
ively obtained in years 1998, 2002, 2005, and 2008 by
uestionnaire, telephone interviews, and review of medical
ecords in 1,126 of 1,175 subjects (95.8%). Median
ollow-up was 6.9 years (25th and 75th percentiles, 4.7 and
.8 years). All events were corroborated by a physician
linded to CACS and SPECT results. The cause of death
as determined by review of medical records, death certif-
cates, and/or telephone interviews with family members or
eferring physicians. In May 2008, all subjects had assess- tent of their vital status through
he Social Security Death Index.
The total cardiac events of car-
iac death, nonfatal MI, and cor-
nary revascularization with by-
ass surgery or percutaneous
pproaches were defined as pri-
ary events. The events of all-
ause mortality and nonfatal MI
ere defined as secondary events.
ardiac death was defined as
eath of any cardiac cause, in-
luding a fatal MI, sudden ar-
hythmic death, or heart failure.
n MI was defined by standard
linical, ECG, and enzymatic
riteria (9,11).
tatistical analysis. Continuous variables are expressed as
ean  SD, and categorical variables are expressed as
requency (percentage). Independent 2-group hypothesis
esting was performed using Wilcoxon rank sum (Mann-
hitney U) tests to compare central tendencies for clinical
ariables and CACS results in subjects who did or did not
ave clinical follow-up data. Baseline characteristics of the
opulation were examined by CACS category and SPECT
esults. The Framingham risk score was calculated in all
ubjects based on standard criteria (12). Because absolute
holesterol and blood pressure measurements were not
vailable, we calculated the Framingham risk score using a
onservative definition for hyperlipidemia (cholesterol 200
o 239 mg/dl) and hypertension (systolic blood pressure 140
o 159 mm Hg). The Kruskal-Wallis analysis of variance
as used to identify significant differences in central ten-
encies of continuously scaled variables over CACS cate-
ories and SPECT results. Contingency table analysis was
erformed using chi-square tests. Kaplan-Meier analysis of
rimary and secondary events was based on discrete CACS
ategories (0 to 10, 11 to 100, 101 to 400, and 400) and
PECT categories (normal, total LV PDS dichotomized at
5%, ischemic PDS dichotomized at 10%). The date of the
rst test (either electron beam tomography or SPECT) was
sed as time 0. Two-sided log-rank tests were used to
etermine significance. Univariate and multivariate Cox pro-
ortional hazards models were used to identify the association
etween time-to-event and baseline clinical characteristics and
he CACS and SPECT results. The clinical characteristics
ncluded in the model were age, sex, smoking status, history of
yperlipidemia, history of hypertension, chest pain, abnormal
esting ECG, family history of CAD and diabetes mellitus,
nd whether exercise was used as the stress modality with
PECT. Interactions between CACS, SPECT, and base-
ine characteristics were assessed for subjects with varying
ACS and SPECT time intervals. The proportionality
ssumption of the Cox models was assessed by including
ime-dependent interactions of each covariate with survival
Abbreviations
and Acronyms
CACS  coronary artery
calcium score
CAD  coronary artery
disease
ECG  electrocardiogram/
electrocardiographic
LV  left ventricular
MI  myocardial infarction
PDS  perfusion defect
size
SPECT  single-photon
emission computed
tomographyime in the model. There was no evidence of violation of
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CACS and SPECT for Predicting Risk November 10, 2009:1872–82his assumption for any covariate. Multivariate likelihood
atio tests were performed to assess entry of clinical,
PECT, and CACS variables into Cox proportional hazard
odels. A type I error rate of alpha  0.05 was used for all
ypothesis tests. The relationship between CACS and
PECT results was determined in the 717 subjects who
nderwent both tests within 6 months. All statistical anal-
ses were performed with Stata version 10 (Stata Statistical
oftware, College Station, Texas).
esults
aseline characteristics. The baseline characteristics are
hown in Table 1. For the entire cohort of 1,175 subjects,
he mean age was 58.1  9.8 years, 73% were male, and
0% were diabetic. Most subjects (83%) were entirely
symptomatic at the time of initial baseline testing, whereas
7% had various atypical chest pain symptoms. The mean
umber of cardiac risk factors was 2.05  1.08. The
ramingham risk score was low in 191 subjects (16.2%),
ntermediate in 915 subjects (77.9%), and high in 69
ubjects (5.9%). The median CACS was 127, with inter-
uartile ranges as follows: first (0 to 14), second (15 to 127),
hird (128 to 440), and fourth (441 to 6,413). An abnormal
PECT result was observed in 151 of 1,175 subjects (13%);
Baseline Demographic, CACS, and Stress SPECTable 1 Baseline Demographic, CACS, and
Total
(n  1,175
Age, yrs 58.1 9.8
Male sex 855 (73%)
Cardiac risk factors
Diabetes 117 (10%)
Hypertension 601 (51%)
Hyperlipidemia 650 (55%)
Smoking history 558 (47%)
Family history of CAD 488 (42%)
Number of cardiac risk factors 2.05 1.08
Framingham risk score 11.2 6.5
Atypical chest pain 203 (17%)
CACS, median (25th–75th percentile) 127 (15–440
CACS results
0–10 276 (24%)
11–100 250 (21%)
101–400 334 (28%)
400 315 (27%)
Ischemic exercise ECG 122 (10%)
Abnormal stress SPECT 151 (13%)
Fixed defect 21 (2%)
Partially reversible defect 94 (8%)
Completely reversible defect 36 (3%)
Quantitative SPECT results
Total PDS (% LV) 1.89 5.8
Ischemic PDS (% LV) 0.8 3.1
Total PDS 15% 44 (4%)
Ischemic PDS 10% 35 (3%)CACS coronary artery calcium score; CAD coronary artery disease; ECG
SPECT  single-photon emission computed tomography.4 (4.0%) had a total PDS 15% and 35 (3.0%) had an
schemic PDS 10%. In the 151 subjects with an abnormal
PECT result, 21 (14%) had a fixed defect, 94 (62%) had a
artially reversible defect, and 36 (24%) had a completely
eversible defect.
The baseline characteristics of subjects with and without
linical follow-up were not significantly different, except that
hose with follow-up were slightly older (58.4 years of age vs.
2.4 years of age, p  0.001), had a higher Framingham risk
core (11.4  6.6 vs. 7.1  3.5, p  0.001), and were more
ikely to have hypertension (52% vs. 37%, p  0.04).
aseline characteristics in subjects with follow-up by
ACS and SPECT category. Subjects with a higher
ACS were older, were more frequently male, and had a
reater frequency of diabetes and hypertension (Table 2).
he mean number of cardiac risk factors and the Framing-
am risk score significantly increased with increasing
ACS. In subjects undergoing exercise stress, the Duke
readmill score did not significantly differ across CACS
ategories.
As shown in Table 3, subjects with a large total (15%)
r ischemic (10%) PDS were older, were more frequently
ale, and had a higher incidence of diabetes and hyperten-
ion compared with those with a normal SPECT result.
ultss SPECT Results
Follow-Up
(n  1,126)
No Follow-Up
(n  49) p Value
58.4 9.8 52.4 10.7 0.001
816 (73%) 39 (80%) 0.36
114 (10%) 3 (6%) 0.5
583 (52%) 18 (37%) 0.04
624 (55%) 26 (53%) 0.86
532 (47%) 26 (53%) 0.52
473 (42%) 15 (31%) 0.15
2.06 1.08 1.8 1.08 0.12
11.4 6.6 7.1 3.5 0.001
199 (18%) 4 (8%) 0.13
127 (14–442) 138 (15–358) 0.99
266 (24%) 10 (20%) 0.73
240 (21%) 10 (20%) 0.98
316 (28%) 18 (37%) 0.25
304 (27%) 11 (22%) 0.59
116 (12%) 6 (12%) 0.84
149 (13%) 2 (4%) 0.1
21 (2%) 0 (0%)
93 (8%) 1 (2%)
35 (3%) 1 (2%)
1.9 5.9 1.5 5.8 0.97
0.8 3.2 0.8 4.7 0.66
43 (4%) 1 (2%) 0.8
34 (3%) 1 (2%) 0.97T ResStres
)
)electrocardiogram; LV left ventricular; PDS perfusion defect size;
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November 10, 2009:1872–82 CACS and SPECT for Predicting Riskhe mean number of cardiac risk factors and the Framing-
am risk score significantly increased based on total and
schemic PDS. Most of the 977 subjects (83.2%) with a
ormal SPECT result had either an intermediate (78.3%) or
high (4.9%) Framingham risk score.
Baseline Demographic and Stress TestDiffere ces by CACS Severity in Subjects With FTable 2 Baseline Demographic and Stress TDifferences by CACS Severity in Su
0–10
(n  266)
11
(n 
Mean CACS 1 2 49
Age, yrs 54 9.7 56
Male sex 135 (51%) 169
Cardiac risk factors
Diabetes 11 (4%) 27
Hypertension 111 (42%) 113
Hyperlipidemia 130 (49%) 137
Smoking history 119 (45%) 103
Family history of CAD 116 (44%) 91
Mean number of risk factors 1.83 1.0 1.96
Framingham risk score 8.01 4.3 10.1
Low 75 (28%) 52
Intermediate 189 (71%) 179
High 2 (1%) 9
Atypical chest pain 83 (31%) 41
Exercise stress with SPECT 229 (86%) 205
Duke treadmill score group*
Low (n 795) 190 (83%) 187
Intermediate (n 143) 38 (16%) 17
High (n 8) 1 (1%) 1
*Group consists of 946 subjects who had treadmill exercise as part o
Abbreviations as in Table 1.
aseline Demographic and Stress Test Differences by SPECT ResuTable 3 Baseline Demographic and Stress Test Differences by
Normal
(n  977)
PDS <15%
(n  106)
PD
(n
Age, yrs 57.7 9.6 62.4 10 6
Male sex 684 (70%) 93 (88%) 3
Cardiac risk factors
Diabetes 89 (9%) 15 (14%) 1
Hypertension 492 (50%) 62 (59%) 2
Hyperlipidemia 540 (55%) 57 (54%) 2
Smoking history 451 (46%) 63 (59%) 1
Family history of CAD 410 (41%) 48 (45%) 1
Mean number of risk factors 2.03 1.08 2.31 1/08 2.3
Framingham risk score 10.8 6.2 14.4 7.0 17
Low 164 (17%) 7 (7%)
Intermediate 765 (78%) 88 (83%) 3
High 48 (5%) 11 (10%) 1
Atypical chest pain 183 (19%) 11 (10%)
Exercise stress with SPECT 843 (86%) 77 (73%) 2
Duke treadmill score group†
Low (n 795) 715 (84%) 58 (75%) 2
Intermediate (n 143) 124 (15%) 15 (20%)
High (n 8) 4 (1%) 4 (5%)Normal SPECT versus IPDS 10%, IPDS 10%. †Group consists of 946 subjects who had treadmill exe
IPDS  ischemic perfusion defect size; other abbreviations as in Table 1.PECT results and CACS severity. The prevalence of an
bnormal SPECT result increased significantly with the
ACS (p  0.001). Although an abnormal SPECT result
as seen in 2% of subjects with a CACS 100, this
ncreased to 9.8% and 31% among those with CACS 101 to
-Up
s With Follow-Up
CACS Severity Groups
)
101–400
(n  316)
>400
(n  304) p Value
210 81 1,082 832 0.001
59.6 8.2 62.5 9.6 0.0001
) 254 (80%) 258 (85%) 0.001
) 36 (11%) 40 (14%) 0.002
) 172 (54%) 187 (62%) 0.001
) 184 (58%) 173 (57%) 0.1
) 156 (49%) 154 (51%) 0.22
) 129 (41%) 137 (45%) 0.35
2.14 1.1 2.27 1.1 0.001
12.4 6.5 14.2 7.1 0.001
) 26 (8%) 20 (7%)
) 267 (84%) 249 (82%)
23 (7%) 35 (12%)
) 44 (14%) 32 (11%) 0.001
) 274 (87%) 238 (78%) 0.01
0.33
) 231 (84%) 187 (79%)
43 (16%) 45 (19%)
0 (0%) 6 (2%)
PECT study.
Subjects With Follow-UpT Results in Subjects With Follow-Up
5%
) p Value
IPDS <10%
(n  115)
IPDS >10%
(n  34) p Value*
.7 0.001 62.8 9.8 64 9.1 0.001
) 0.0001 101 (88%) 31 (91%) 0.0001
) 0.004 15 (13%) 10 (29%) 0.0001
) 0.031 69 (60%) 22 (65%) 0.046
) 0.59 60 (52%) 24 (71%) 0.16
) 0.11 64 (56%) 17 (50%) 0.23
) 0.51 52 (45%) 11 (32%) 0.41
.17 0.01 2.26 1.08 2.47 1.19 0.008
.1 0.001 14.6 7.0 17.6 8.5 0.001
7 (6%) 2 (6%)
) 95 (83%) 24 (71%)
) 13 (11%) 8 (23%)
) 0.06 14 (12%) 2 (6%) 0.04
) 0.001 82 (71%) 21 (62%) 0.0001
0.0001 0.005
) 65 (79%) 15 (71%)
) 14 (17%) 5 (24%)
3 (4%) 1 (5%)ollowest
bject
–100
240
 26
 9.6
(70%
(11%
(47%
(57%
(43%
(38%
 1.0
 6.2
(22%
(75%
(4%)
(17%
(85%
(91%
(8%)
(1%)lts inSPEC
S >1
 43
5 8
9 (91%
0 (23%
9 (67%
7 (63%
8 (42%
5 (35%
0 1
.3 8
2 (5%)
1 (72%
0 (23%
5 (12%
6 (61%
2 (85%
4 (15%
0 (0%)rcise as part of their SPECT study.
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CACS and SPECT for Predicting Risk November 10, 2009:1872–8200 and 400, respectively (p  0.001). No one with a
ACS 100 had a high-risk SPECT profile based on the
tress-induced total or ischemic LV PDS, but this signifi-
antly increased as the CACS increased from moderate
2.1% and 1.7%) to severe (10.8% and 8.9%), respectively
p  0.001) (Fig. 1).
ardiac events. Over a median follow-up of 6.9 years,
here were 145 primary events (33 cardiac deaths, 22
onfatal MIs, and 90 revascularization procedures) and 109
econdary events (87 deaths and 22 nonfatal MIs). Most
oronary revascularization procedures (n  77 or 86%) were
erformed late (60 days) after electron beam tomography
r SPECT imaging. Only 2 of 977 subjects (0.20%) with a
ormal SPECT result versus 11 of 149 (7.4%) with an
bnormal SPECT result underwent early revascularization
p  0.001). The prevalence of early revascularization
rocedures in each CACS group is as follows: 0 to 10: 0%;
1 to 100: 0%; 101 to 400: 1.3%; and 400: 3.0%.
redictors of events. Univariate predictors of total cardiac
vents were age, the presence of hypertension and diabetes
ellitus, increasing CACS, inability to exercise, an
ntermediate- or high-risk Duke treadmill score, and an
0
5
10
15
20
25
30
35
Abnormal SPECT
Total PDS >15% LV
Ischemic PDS >10% LV
%
 S
u
b
je
ct
s
CACS
1%
2.3%
9.8%
31%
2.1% 1.7%
10.8%
8.9%
p <0.001 across CACS groups 
for all SPECT categories
Figure 1 Relation Between CACS and SPECT Results
Relation between coronary artery calcium score (CACS) severity and stress
single-photon emission computed tomography (SPECT) results in 717 subjects
who underwent both tests within 6 months. The percentage of subjects with an
abnormal SPECT result (p  0.001) and those with a large stress-induced total
(15%) and ischemic (10%) left ventricular (LV) perfusion defect size (PDS)
(p  0.001) significantly increased with increasing CACS severity.
ultivariable Predictors of EventsTable 4 Multivariable Predictors of Events
Total Cardiac Events
Hazard Ratio 95% CI
Age (per yr) 0.99 0.98–1.01
Female sex 1.35 0.88–2.08
Inability to exercise 1.11 0.72–1.71
CACS (per group increment) 1.65 1.34–2.0
SPECT PDS 15% LV 4.16 2.55–7.10I  confidence interval; other abbreviations as in Tables 1 and 2.bnormal SPECT result (all p  0.05). Univariate predic-
ors of all-cause death/MI were age, inability to exercise,
n intermediate- or high-risk Duke treadmill score, an
ncreasing CACS, and an abnormal SPECT result (all
 0.05). Independent predictors of total cardiac events by
ultivariate analysis were increasing CACS severity and a
igh-risk SPECT result (LV PDS 15%). Independent
redictors of all-cause death/MI were age, female sex,
nability to exercise, increasing CACS, and a high-risk
PECT result (Table 4). An ischemic PDS 10% was also
n important predictor of total cardiac events (hazard ratio
HR]: 4.36; 95% confidence interval [CI]: 2.44 to 7.77;
 0.01) and death/MI (HR: 2.67; 95% CI: 1.31 to 5.44;
 0.007) when substituted for PDS 15% in the original
odel. A separate analysis limited to the 946 subjects who
ad treadmill exercise showed that an intermediate- or
igh-risk Duke treadmill score was also an independent
redictor of total cardiac events (HR: 1.82; 95% CI: 1.12 to
.94; p  0.02).
ardiac events based on CACS and SPECT results. The
isk for total cardiac events and all-cause death/MI increased
ignificantly with increasing CACS severity (Fig. 2) and the
resence and extent of SPECT abnormalcy (Figs. 3 and 4). In
ubjects with a normal SPECT result, the total and all-cause
eath/MI event rates remained low at 1%/year and 0.5%/
ear over the first 4 years of follow-up, respectively (Figs. 3 and
). However, subjects with a large (15%) stress-induced LV
DS had a significantly higher annualized total (9.6% vs. 3.8%,
 0.001) and all-cause death/MI (6.1% vs. 2.3%; p 0.001)
vent rate than those with smaller defects, respectively, and this
as observed throughout the follow-up period (Fig. 3).
imilarly, subjects with a large (10%) ischemic LV PDS
ad significantly higher annualized total (11.4% vs. 4.0%;
 0.001) and all-cause death/MI (7.6% vs. 3.4%; p 
.001) event rates than those with smaller ischemic defects,
espectively (Fig. 4).
The integration of CACS and SPECT results further
mproved risk stratification (Fig. 5). Subjects with a mod-
rate or severe CACS had significantly higher annualized
verall and all-cause death/MI event rates when SPECT
as abnormal (5.9% and 3.5%) versus normal (2.0% and
.6%), respectively (both p  0.001) (Fig. 5). This was
articularly true in those who had a large (15%) stress-
nduced PDS in which the annualized overall total cardiac
All-Cause Death/Myocardial Infarction
p Value Hazard Ratio 95% CI p Value
0.62 1.05 1.03–1.08 0.0001
0.17 1.80 1.15–2.81 0.01
0.64 1.76 1.14–2.74 0.01
0.001 1.37 1.10–1.69 0.004
0.001 2.21 1.15–4.26 0.02
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November 10, 2009:1872–82 CACS and SPECT for Predicting Risknd all-cause death/MI event rates increased to 10.3% and
.1%, as compared with 4.3% and 2.6% in those with an LV
DS 15% (both p  0.001). In subjects who had a large
10%) stress-induced ischemic PDS, the annualized over-
ll total cardiac and all-cause death/MI event rates also
ncreased to 12% and 7.8%, as compared with 4.6% and
.6% in those with an ischemic PDS 10% (both p 
.001). Conversely, in subjects with a normal SPECT
esult, the total cardiac and all-cause death/MI event rates
ignificantly increased with increasing CACS severity
Fig. 5).
Figure 2 Event Rates Based on CACS Severity
Total cardiac death, myocardial infarction (MI), and coronary revascularization
(A) and all-cause death/MI (B) event rates based on CACS severity. Abbreviations
Figure 3 Event Rates Based on SPECT Results: Total Perfusion
Total cardiac death, MI, and coronary revascularization (A) and all-cause death/M
results of normal, abnormal with an LV PDS 15%, and abnormal with an LV PDSThe improvement in predicting risk by combining CACS
nd SPECT results was also analyzed relative to the
owest-risk cohort (i.e., subjects with a normal SPECT
esult and CACS 10). By Cox proportional hazard mod-
ling, the relative risk for total cardiac and all-cause
eath/MI events significantly increased in subjects with a
ormal SPECT result when CACS exceeded 400 (Table 5).
ime point analysis showed separation of the survival curves
etween the minimal (0 to 10) and severe (400) CACS
roups at 3 years after initial testing for total cardiac events
p  0.02) and at 5 years for death/MI (p  0.02) (Fig. 6).
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CACS and SPECT for Predicting Risk November 10, 2009:1872–82his indicates that when the CACS is severe, the “warranty
eriod,” for a normal SPECT result expires within several
ears.
ncremental prognostic value of CACS and SPECT
esults over clinical information. The addition of high-
isk SPECT variables (i.e., total PDS 15%, ischemic
DS 10%) significantly increased the predictive power
f the clinical model alone (Fig. 7). The global chi-square
tatistic (likelihood ratio) increased from 40.8 to 78.2 (p
0.001, total cardiac events) and from 82.6 to 90.9 (p 
.02, all-cause death/MI) with the addition of total PDS.
ikewise, addition of ischemic PDS to the clinical model
ncreased the global chi-square value from 40.8 to 76.3
p  0.001, total cardiac events) and from 82.6 to 91.6
Figure 4 Event Rates Based on SPECT Results: Ischemic Perfu
Total cardiac death, MI, and coronary revascularization (A) and all-cause death/M
results of normal, abnormal with a 10% ischemic PDS, and abnormal with a 10
A
Figure 5 Adjusted Annualized Event Rates Based on CACS and
Adjusted annualized total cardiac death, MI, and coronary revascularization (A) an
all-cause death/MI (B) event rates based on CACS and SPECT results. Abbreviatiop  0.01, all-cause death/MI). Adding CACS results to
he combined SPECT and clinical information further
ncreased the global chi-square statistic for predicting
oth total cardiac events and death/MI irrespective of
hether total or ischemic PDS was used as the SPECT
ariable.
mpact of symptoms and testing intervals on outcomes.
he annual event rates in different CACS and SPECT
roups among subjects who did or did not have chest pain
ere not statistically significant. The testing interval be-
ween SPECT and electron beam tomography did not
ignificantly modify the effect of CACS and perfusion
esults on outcome (interaction p  0.23 for cardiac events
nd 0.42 for death/MI).
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hemic PDS. Abbreviations as in Figures 1 and 2.
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November 10, 2009:1872–82 CACS and SPECT for Predicting Riskiscussion
recisely defining short- and long-term cardiac risk is
ivotal for guiding therapy in individual patients. The
urrent study followed up a large cohort of generally
symptomatic subjects for nearly a decade and shows that
ACS and SPECT results provide both independent and
omplementary prognostic information. The most provoc-
tive finding we report is that although a normal SPECT
esult predicts excellent short-term event-free survival,
ong-term outcome is significantly worse if the CACS is
evere. This is not altogether surprising because the CACS
s directly related to the extent of coronary atherosclerotic
laque burden (13), which cannot be measured by func-
ional SPECT imaging. Based on results from several
linical trials (14–16), current American College of Cardi-
logy Foundation/American Society of Nuclear Cardiology
uidelines recommend SPECT imaging to assess for ische-
ia in asymptomatic subjects with a severe (400) CACS
17). Our results support a more important role for CACS
esting among patients with a normal SPECT result within
urrent guideline recommendations. Doing so would help to
dentify those at high long-term risk for cardiac events, in
Figure 6 Event Rates in Subjects With a Normal SPECT Result
Total cardiac death, MI, and coronary revascularization (A) and all-cause death/M
rates based on CACS severity in subjects with a normal stress SPECT result. Abbr
ubjects With a Normal Stress SPECT: Relative Risk of Events BasTable 5 Subjects With a Normal Stress SPECT: Relative Risk o
Total Cardiac Events
Normal SPECT Hazard Ratio 95% CI
CACS 0–10 1
CACS 11–100 1.28 0.60–2.74
CACS 101–400 1.53 0.75–3.12
CACS 400 3.55 1.78–7.09
bbreviations as in Tables 1 and 4.hom an earlier focus on aggressive risk factor modification
nd other medical therapeutic measures may be beneficial.
PECT for assessing risk. Over 2 decades of clinical trials
n over 100,000 patients have established the central role of
tress SPECT in the routine clinical management of sub-
ects with suspected or known CAD (3). A normal SPECT
esult generally defines a group with a 1% annual risk of
ardiac death and/or nonfatal MI, which increases to
pproximately 6% if the study result is abnormal (3,4). In
atients with a clearly abnormal SPECT, total PDS and the
resence and extent of residual ischemia further define high
isk (18). Consistent with these prior observations, our subjects
ith a normal SPECT result also had a very low annual
ll-cause death/MI rate (1%), which increased significantly
mong those with large total (6.1%) or ischemic (7.6%)
erfusion defects, respectively.
Despite the well-recognized role of SPECT imaging in
isk stratification, there are certain patient populations in
hom a normal study result may not necessarily confer the
ame low risk (3,19,20). In addition, the “warranty period”
f a normal SPECT result decreases significantly in patients
ith diabetes or known CAD and in those unable to
d on CACS Severity
vent
ns as in Figures 1 and 2.
n CACS Severitynts Based on CACS Severity
All-Cause Death/Myocardial Infarction
alue Hazard Ratio 95% CI p Value
1
52 1.96 0.89–4.3 0.09
24 1.72 0.81–3.63 0.15
001 2.75 1.29–5.85 0.008Base
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CACS and SPECT for Predicting Risk November 10, 2009:1872–82xercise (21). Our results show that the addition of CACS
ore precisely defines this “warranty period,” because car-
iac event rates significantly increase beginning 3 years after
normal SPECT result when the CACS is severe. More
igilant risk factor modification in such high-risk individu-
ls would, therefore, seem warranted.
ACS for assessing risk. Calcium scoring has been stud-
ed extensively over the past decade for predicting outcome
n generally asymptomatic subjects at intermediate clinical
isk for CAD (1,2). A CACS of 0 consistently identifies a
ery-low-risk cohort, even among clinically high-risk groups
uch as diabetic patients (22). In our study, only 1 cardiac
eath and 2 nonfatal MIs occurred over 7 years in the 266
ubjects (1.2%) with a CACS 10. This finding is very
imilar to those reported from other large prospective
bservational population-based studies (23). Conversely,
ardiac events significantly increase with increasing CACS,
nd this occurs across all ethnic groups (2). Interestingly,
ur study showed that the CACS was a stronger predictor
f cardiac events than diabetes mellitus, which has been
onsidered a coronary heart disease risk equivalent (24).
hy integrate CACS with SPECT results? Combining
n anatomic assessment of coronary atherosclerotic plaque
urden with a functional assessment of myocardial ischemia
ay temporally refine risk stratification among subjects at
arying clinical risk. One could envision SPECT providing
better short-term risk assessment because it identifies the
unctional significance of more advanced stages of CAD.
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Figure 7 Incremental Prognostic Value of Clinical, SPECT, and
Incremental predictive value of CACS and stress SPECT results over clinical inform
able. (C and D) Ischemic perfusion defect size (IPDS) was used as the SPECT var
family history of coronary artery disease, chest pain, abnormal resting electrocardiowever, the CACS may better estimate longer-term brognosis because of its ability to detect varying degrees of
oronary atherosclerosis before the development of stress-
nduced myocardial ischemia.
Our results and those of others (25,26) support this
oncept. In a recent study following up asymptomatic
iabetic subjects for more than 2 years, CACS and the
xtent of ischemic myocardium by SPECT both predicted
atient outcome (25). However, combining CACS and
PECT results significantly improved risk stratification,
ith no events in patients with a normal SPECT result and
low CACS (100) but a 10% event rate in those with a
ACS 1,000 (25). Conversely, in patients with a CACS
100, the extent of stress-induced ischemia further pre-
icted outcome. We report similar observations, with the
otal cardiac event rate increasing from 2.0% to 5.9%
p  0.001) in our subjects with a CACS 100 based on
hether the SPECT result was normal or abnormal. In
nother study of predominantly symptomatic patients with
high pre-test likelihood of CAD, CACS added prognostic
alue to rubidium-82 perfusion results (26). In contrast,
nother study reported no additional risk information from
ACS when the SPECT result was normal (27). However,
his seeming discrepancy with our study results is probably
elated to the relatively short follow-up period of only 2
ears.
In addition to the size of our patient cohort, the 7-year
ollow-up is longer than performed in any previous study,
llowing us to better clarify the temporal interrelationship
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November 10, 2009:1872–82 CACS and SPECT for Predicting Riskata indicate that a severe CACS even among scintigraphi-
ally normal patients defines a group at considerable risk for
vents if followed up for a long enough period of time.
lthough patients with a normal SPECT result and low
10) CACS have an excellent overall prognosis, a normal
PECT result may lead to a false sense of long-term
ecurity among those with an underlying severe CACS in
hom the annual overall cardiac event rate approached 3%.
Our results support performing a CACS in patients at
ntermediate or high clinical risk for CAD who have a
ormal SPECT result because approximately 20% will have
CACS of at least moderate severity that cannot be
redicted from the patient’s clinical profile (28). In this
egard, calcium scoring allows identification of high-risk
ndividuals among the heterogeneous group of relatively
ow-risk patients with a normal SPECT result. The value of
ACS as a high-risk marker may extend beyond its prog-
ostic implications. Although not specifically addressed in
his study, identification of early atherosclerosis, defined by
ACS, may improve patient outcome through earlier and
ore intensive risk factor modification and treatment of
yperlipidemia. For example, preliminary data suggest that
ntensive treatment of hyperlipidemia may reduce CACS
rogression (29) and thereby decrease cardiac event rates
30). In a similar fashion, initiating statin therapy in patients
ith a surrogate marker of high risk (i.e., C-reactive
rotein) was recently shown to reduce cardiac events despite
relatively normal low-density lipoprotein cholesterol level
31). The hypothesis that selectively targeting therapy based
n CACS and SPECT results may reduce downstream
edical and overall health care costs is one that warrants
urther study.
tudy limitations. First, this was not an epidemiologic
tudy, so it comes with unavoidable patient selection bias.
fter an abnormal screening CACS, SPECT was variably
ecommended, which probably explains why a relatively
arge proportion of our cohort had a CACS 100. How-
ver, many of our subjects even with a CACS 10 also
nderwent SPECT because they had chest pain symptoms
hat required further clarification. Second, CACS and
PECT results were available to subjects and referring
hysicians, who could then initiate lifestyle changes and/or
harmacological interventions and potentially reduce car-
iac event rates. However, this should have biased our study
gainst observing a relationship between CACS and cardiac
vents. Rather, our data are consistent with previous reports
howing the independent prognostic value of SPECT (3)
nd CACS (1,2). Third, not all studies were performed in
lose temporal relationship to each other. However, the
uration of the interval between performing CACS and
PECT imaging did not affect our results.
onclusions
he CACS and stress SPECT results are independent and
omplementary for predicting events. A severe CACSdentifies a subgroup of subjects at high long-term risk even
n the presence of a normal stress SPECT study. Our results
upport a strategy of adding CACS testing in patients with
normal SPECT result to identify those at high long-term
isk for cardiac events. In these patients, earlier aggressive
isk factor modification may deter further progression of
oronary atherosclerosis and improve outcome. The cost
ffectiveness of such an approach will require further study.
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